Compare TMDX & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TMDX | NVST |
|---|---|---|
| Founded | 1998 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.3B |
| IPO Year | 2019 | 2019 |
| Metric | TMDX | NVST |
|---|---|---|
| Price | $136.66 | $20.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 12 |
| Target Price | ★ $133.00 | $20.91 |
| AVG Volume (30 Days) | 835.5K | ★ 1.8M |
| Earning Date | 10-29-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 170.70 | N/A |
| EPS | ★ 2.54 | 0.09 |
| Revenue | $566,354,000.00 | ★ $2,621,800,000.00 |
| Revenue This Year | $38.84 | $7.42 |
| Revenue Next Year | $20.43 | $3.63 |
| P/E Ratio | ★ $53.83 | $235.20 |
| Revenue Growth | ★ 41.20 | 4.73 |
| 52 Week Low | $55.00 | $14.22 |
| 52 Week High | $156.00 | $22.68 |
| Indicator | TMDX | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 54.31 | 51.10 |
| Support Level | $133.50 | $20.17 |
| Resistance Level | $156.00 | $21.13 |
| Average True Range (ATR) | 8.50 | 0.52 |
| MACD | 0.41 | 0.04 |
| Stochastic Oscillator | 55.98 | 61.44 |
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.